Related Experiment Videos

[Phenotypic and functional alterations of mesangial cells in patients with diabetic nephropathy]

Z Liu1, Z Chen, Y Li

  • 1Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.

Abstract

Insights

Glomerular mesangial cells (MC) in diabetic nephropathy (DN) show hypertrophy, increased turnover, and excessive extracellular matrix production. These cells also exhibit altered glucose metabolism, including enhanced glucose transporter 1 (GLUT1) expression and increased hexosamine pathway flux, contributing to DN pathogenesis.

Area of Science:

  • Nephrology
  • Cell Biology
  • Metabolic Disorders

Context:

  • Diabetic nephropathy (DN) is a major complication of diabetes mellitus.
  • Glomerular mesangial cells (MC) play a critical role in the structural and functional integrity of the glomerulus.
  • Understanding MC changes in DN is crucial for developing targeted therapies.

Purpose:

  • To investigate the phenotypic and functional alterations of MC in type II diabetic nephropathy.
  • To analyze changes in cell size, proliferation, extracellular matrix production, and glucose metabolism in MC from DN patients.

Summary:

  • MC from type II DN patients exhibited significant hypertrophy (increased cell volume) and accelerated proliferation (higher 3H-Tdr incorporation, shorter doubling time) compared to controls.
  • DN-MC showed increased synthesis of alpha-smooth muscle actin and extracellular matrix components like fibronectin and laminin.
  • Enhanced expression of glucose transporter 1 (GLUT1) at both mRNA and protein levels was observed in DN-MC, leading to increased glucose uptake.
  • Activity of glutamine: fructose-6-P aminotransferase (GFAT), a key enzyme in the hexosamine pathway, was elevated in DN-MC, indicating increased glucose flux through this metabolic route.

Impact:

  • The study identifies key cellular and metabolic changes in MC that underlie the pathogenesis of diabetic nephropathy.
  • These findings highlight MC as a central player in DN development and suggest potential therapeutic targets related to cell growth, matrix production, and glucose metabolism.

Related Concept Videos